Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics
Novo itself is beginning to generate data suggesting semaglutide may actually affect biological processes linked to aging, not just body weight.
Original Source
Read the full article at Fortune →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.